2 Information about relugolix CT

Marketing authorisation indication

2.1

Relugolix–estradiol–norethisterone (relugolix combination therapy [CT]; Ryeqo, Gedeon Richter) is indicated 'in adult women of reproductive age for symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis'.

Dosage in the marketing authorisation

Price

2.3

The list price for relugolix CT is £72 per pack of 28 tablets (excluding VAT; BNF online, accessed February 2025).

2.4

Costs may vary in different settings because of negotiated procurement discounts.